Brad Bolzon is Chairman and Managing Director of Versant, with over 20 years as a venture capitalist and 13 years in pharmaceutical leadership. He has led successful investments and built the Versant team.
At firms with a similar stage, sector and check size.




One email when Brad's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckBrad Bolzon is Chairman and Managing Director of Versant, with over 20 years as a venture capitalist and 13 years in pharmaceutical leadership. He has led successful investments and built the Versant team.
Versant Ventures has not reported a check size. It invests at seed, series a, series b.
A warm intro from a founder Versant Ventures backed works best.
executive roles at Eli Lilly; Executive Vice President, Global Head of Business Development, Licensing & Alliances at Roche; Eli Lilly.
Last updated 2026-10-15. Is this you? Ask for a correction.